Introduction
Although liver scanning has been proposed as a sensitive test for the detection of hepatic metastases, its exact role in the management of a patient with malignancy has not been completely defined. In the present study patients with histological evidence of hepatic cancer were analysed in an attempt to determine the sensitivity of the liver scan for the detection of hepatic malignancy, especially metastasis, and the indications for a liver scan in patients known to have cancer in some other region of the body.
Materials and Methods
Seventy-two patients with proved hepatic malignancy (18 primary and 54 metastatic) who had had liver scans were studied. This group is referred to subsequently as the " scan group." In 68 cases the histological proof was obtained by needle biopsy and the interval between the two procedures was one week or less. In four cases histological confirmation was obtained at necropsy performed within one month of scanning. Only those biochemical tests done within two days of the radionuclide procedure were evaluated. Liver weight was calculated in each case from the scanning images (anterior and right lateral views) by the method of Rollo and DeLand (1968) Hepatormegaly.-In the " scan group " patients altogether 94 % had significant hepatic enlargement (greater than 2 S.D. from the mean) (Table II) . One patient with hepatoma and four with liver metastases had normal liver weights. This was in marked contrast to the incidence of hepatomegaly in the necropsy group. The possible significance of this finding is discussed elsewhere in the paper.
Splenomegaly.-Of interest was the finding that 33 % of the patients with primary carcinoma of the liver and 7% of the patients with metastatic tumours of the liver showed splenomegaly in the scan. The incidence of splenic enlargement as observed from the anterior scan views is also given in Table II. (Table IV) . Splenic metastases were present in one case of hepatoma, while in the metastatic group 19 patients had splenic metastases. Five of the latter had splenomegaly. In two of these five cases the metastases were small and capsular and thus were not the causative factor for the splenomegaly. Twelve of the sixteen (75%) patients with hepatoma had evidence of coexistent cirrhosis (Laennec or postnecrotic type), while in those with metastases to the liver only two (2 %) had coexistent cirrhosis. 
Discussion
The present study supports the concept that liver scanning is helpful in predicting which patients will subsequently be found by biopsy to have metastatic or primary carcinoma of the liver. Eight-eight per cent. of the-patients who had liver-punch biopsies that showed metastatic cancer (44 out of 50 cases) had well-defined focal defects in the liver scan. Thus the incidence B yI MEDICAL JOUMAsL of false-negative liver scans in the presence of metastases which could be detected by biopsy was relatively low. Our data also suggested that liver scanning seemed to be carried out most often when the clinician detected enlargement of the liver. This was indicated by the difference in the incidence of hepatomegaly in the presence of liver metastases between the scan group and necropsy group of patients.
In this study we have also evaluated the role of biochemical tests as a screening procedure in the detection of hepatic malignancy. A high serum alkaline phosphatase has been considered to be more specific for hepatic metastasis than other liver-function tests in patients without bone disease or biliary obstruction (Smith and Williams, 1968 ; Yesner and Conn, 1963) . But this test can be abnormal in a variety of other conditions, such as chronic infiltrative diseases of the liver due to sarcoidosis, Hodgkin's disease, tuberculosis, infectious hepatitis, or infectious mononucleosis (Ross et al., 1956) . Only 30% of thepatients with primary carcinoma of the liver and 56% of those with metastatic liver cancer had high serum alkaline phosphatase. B.S.P. retention is a very sensitive test, but is also non-specific. No single biochemical test is both high-specific and sensitive for hepatic malignancy. Our results indicate that too much significance should not be given to the biochemical tests in predicting the presence or absence of hepatic malignancy.
The most specific method of establishing the diagnosis is by tissue examination-by either open or closed biopsy. Blind needle biopsy, however, occasionally fails to detect the lesion. In one large series of needle biopsies of the liver performed on cadavers immediately before the necropsy, metastases were detected in less than 50 % of cases with hepatic metastases . Even large hepatomas may be missed by blind biopsy (New England 7ournal of Medicine, 1968) . Liver scanning helps in the selection of the proper biopsy site. In the present series random needle biopsies were initially negative in five cases, while subsequent biopsies after proper selection of the biopsy site from the scan images yielded positive results.
Although the incidence of false-positive liver scans has been reported to be as high as 29% in selected patients with cirrhosis (Johnson and Sweeney, 1967) , which occasionally poses problems in the diagnosis of hepatoma, we believe that with proper technique and interpretation the number of false-positive scans can be reduced. The incidence of false-negative or non-specific scan pattern (without clear-cut focal defects) in our series of primary carcinoma of the liver was 23 % ; if we consider cases of hepatoma alone this incidence becomes 25 %. A nonhomogeneous distribution pattern (Type 2) is not unexpected in hepatpma because of the frequent association of cirrhosis and hepatoma. Fifty per cent. of hepatoma patients in the scan group and 75 % in the necropsy group had coexistent cirrhosis. Hepatoma occurs as a complication in up to 33 % of cases with alcoholic cirrhosis (Stone et al., 1968) . A well-defined focal defect in the scan of a cirrhotic patient always increases the probability of hepatoma. Absence of clear-cut defects, however, does not exclude the presence of hepatoma. Single clear-cut focal defects were seen in 56% of cases with primary liver carcinoma. Since hepatomas can originate as a multicentric tumour (Passaro, 1966) , multiple focal defects do occur, as seen in 21 % of our cases. None of the patients with primary liver carcinoma had a normal scan pattern.
Despite the fact that focal defects can occur in patients with liver abscesses, cysts, angiomas, etc. (McAfee et al., 1965) 
